177 related articles for article (PubMed ID: 1430231)
1. Immune complex processing in patients with systemic lupus erythematosus. In vivo imaging and clearance studies.
Davies KA; Peters AM; Beynon HL; Walport MJ
J Clin Invest; 1992 Nov; 90(5):2075-83. PubMed ID: 1430231
[TBL] [Abstract][Full Text] [Related]
2. Splenic uptake of immune complexes in man is complement-dependent.
Davies KA; Erlendsson K; Beynon HL; Peters AM; Steinsson K; Valdimarsson H; Walport MJ
J Immunol; 1993 Oct; 151(7):3866-73. PubMed ID: 8376807
[TBL] [Abstract][Full Text] [Related]
3. The role of hypocomplementaemia and low erythrocyte complement receptor type 1 numbers in determining abnormal immune complex clearance in humans.
Schifferli JA; Ng YC; Paccaud JP; Walport MJ
Clin Exp Immunol; 1989 Mar; 75(3):329-35. PubMed ID: 2522842
[TBL] [Abstract][Full Text] [Related]
4. Defective Fc-dependent processing of immune complexes in patients with systemic lupus erythematosus.
Davies KA; Robson MG; Peters AM; Norsworthy P; Nash JT; Walport MJ
Arthritis Rheum; 2002 Apr; 46(4):1028-38. PubMed ID: 11953981
[TBL] [Abstract][Full Text] [Related]
5. Mononuclear phagocyte system in SLE. II. A kinetic model of immune complex handling in systemic lupus erythematosus.
Meryhew NL; Kimberly RP; Messner RP; Runquist OA
J Immunol; 1986 Jul; 137(1):97-102. PubMed ID: 3486919
[TBL] [Abstract][Full Text] [Related]
6. Modulation of CR1 transcript in systemic lupus erythematosus (SLE) by IFN-gamma and immune complex.
Arora V; Mondal AM; Grover R; Kumar A; Chattopadhyay P; Das N
Mol Immunol; 2007 Mar; 44(7):1722-8. PubMed ID: 17049990
[TBL] [Abstract][Full Text] [Related]
7. Abnormal clearance of soluble aggregates of human immunoglobulin G in patients with systemic lupus erythematosus.
Lobatto S; Daha MR; Breedveld FC; Pauwels EK; Evers-Schouten JH; Voetman AA; Cats A; Van Es LA
Clin Exp Immunol; 1988 Apr; 72(1):55-9. PubMed ID: 3396221
[TBL] [Abstract][Full Text] [Related]
8. CR1 on erythrocytes of Brazilian systemic lupus erythematosus patients: the influence of disease activity on expression and ability of this receptor to bind immune complexes opsonized with complement from normal human serum.
Marzocchi-Machado CM; Alves CM; Azzolini AE; Polizello AC; Carvalho IF; Lucisano-Valim YM
J Autoimmun; 2005 Dec; 25(4):289-97. PubMed ID: 16289666
[TBL] [Abstract][Full Text] [Related]
9. The clearance of tetanus toxoid/anti-tetanus toxoid immune complexes from the circulation of humans. Complement- and erythrocyte complement receptor 1-dependent mechanisms.
Schifferli JA; Ng YC; Estreicher J; Walport MJ
J Immunol; 1988 Feb; 140(3):899-904. PubMed ID: 2963069
[TBL] [Abstract][Full Text] [Related]
10. Immune adherence and clearance of hepatitis B surface Ag/Ab complexes is abnormal in patients with systemic lupus erythematosus (SLE).
Madi N; Steiger G; Estreicher J; Schifferli JA
Clin Exp Immunol; 1991 Sep; 85(3):373-8. PubMed ID: 1893616
[TBL] [Abstract][Full Text] [Related]
11. Immune complex clearance by complement receptor type 1 in SLE.
Kavai M
Autoimmun Rev; 2008 Dec; 8(2):160-4. PubMed ID: 18602499
[TBL] [Abstract][Full Text] [Related]
12. Abnormal immune adherence and elimination of hepatitis B surface antigen/antibody complexes in patients with AIDS.
Madi N; Steiger G; Estreicher J; Schifferli JA
J Immunol; 1992 Feb; 148(3):723-8. PubMed ID: 1530955
[TBL] [Abstract][Full Text] [Related]
13. Diminished ability of erythrocytes from patients with systemic lupus erythematosus to limit opsonized immune complex deposition on leukocytes and activation of granulocytes.
Nielsen CH; Rasmussen JM; Voss A; Junker P; Leslie RG
Arthritis Rheum; 1998 Apr; 41(4):613-22. PubMed ID: 9550470
[TBL] [Abstract][Full Text] [Related]
14. Immune complex clearance by monocytes and macrophages in systemic lupus erythematosus.
Kavai M; Szegedi G
Autoimmun Rev; 2007 Aug; 6(7):497-502. PubMed ID: 17643939
[TBL] [Abstract][Full Text] [Related]
15. Clearance pathways of soluble immune complexes in the pig. Insights into the adaptive nature of antigen clearance in humans.
Davies KA; Chapman PT; Norsworthy PJ; Jamar F; Athanassiou P; Keelan ET; Harrison AA; Binns RM; Haskard DO; Walport MJ
J Immunol; 1995 Dec; 155(12):5760-8. PubMed ID: 7499864
[TBL] [Abstract][Full Text] [Related]
16. Differences among immune complexes: association of C1q in SLE immune complexes with renal disease.
Greisman SG; Redecha PB; Kimberly RP; Christian CL
J Immunol; 1987 Feb; 138(3):739-45. PubMed ID: 3492531
[TBL] [Abstract][Full Text] [Related]
17. Restoration of normal interactions between immune complexes and systemic lupus erythematosus blood cells by normal serum.
Medof ME; Oger JJ; Antel JP; Prince GM
J Clin Lab Immunol; 1982 Feb; 7(2):93-103. PubMed ID: 7069786
[TBL] [Abstract][Full Text] [Related]
18. Defective immune adherence and elimination of hepatitis B surface antigen/antibody complexes in patients with mixed essential cryoglobulinemia type II.
Madi N; Steiger G; Estreicher J; Schifferli JA
J Immunol; 1991 Jul; 147(2):495-502. PubMed ID: 2071892
[TBL] [Abstract][Full Text] [Related]
19. Reduced complement receptor 1 (CR1, CD35) transcription in systemic lupus erythematosus.
Arora V; Verma J; Dutta R; Marwah V; Kumar A; Das N
Mol Immunol; 2004 Jun; 41(4):449-56. PubMed ID: 15163541
[TBL] [Abstract][Full Text] [Related]
20. Immune adherence of nascent hepatitis B surface antigen-antibody complexes in vivo in humans.
Madi N; Paccaud JP; Steiger G; Schifferli JA
Clin Exp Immunol; 1989 Nov; 78(2):201-6. PubMed ID: 12412749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
